Polski Bank Komórek Macierzystych, together with the Swedish company listed on the stock exchange, NextCell Pharma AB, will launch the production of the innovative CAR-T cell therapy. NextCell has just purchased a block of shares in the FamiCordTx company established two years ago – a company owned by Polski Bank Komórek Macierzystych (FamiCord Group). Loewen advised in this process.

– Cooperation with this type of innovative companies is a great pleasure of participating in projects whose potential goes far beyond our “here and now” – emphasizes Szymon Kaczmarek, partner at Loewen Legal Hub, on whose behalf he handled this process.

Loewen specializes in handling all types of transactions on the capital market – domestic and foreign entities.